08/08/2010 // North Carolina, US // Get Cancer Answers // News Desk
Washington, D.C. – A new study suggests an iron-eliminating protein may be useful in the fight against breast cancer. As reported by AFP, researchers found that ferroportin may be used for treatment against the disease as well as to slow tumor growth and in the prediction of patient outcomes.
Suzy Torti, an associate professor of biochemistry at Wake Forest University Baptist Medical Center in North Carolina, and a lead study investigator, is quoted in the report as stating of the research findings, “Because ferroportin can remove iron from the cell, when we put the protein back into the cell, the ferroportin removed the cancer’s growth stimulus…Our findings suggest that ferroportin is a substantial influence on the behavior of the cancer.”
More information about the study may be available in Science Translational Medicine.
The latest in Cancer News
Photo Credit: Wikipedia User MesserWoland